Sterling Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-37,751	Closed	-$863K	–	868
2018 Q2	$863K	Sell	37,751 -45	-0.1%	-$1.03K	0.01%	664
2018 Q1	$1.08M	Hold	37,796	–	–	0.01%	587
2017 Q4	$798K	Buy	+37,796	New	+$798K	0.01%	697